Discovery of LDD‑1075 as a potent FLT3 inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of LDD‑1075 as a potent FLT3 inhibitor

Published:2019-03-01 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yoon Kyoung¹,Lee Hyo¹,Chung Hye¹,Lee Jungeun²,Choi Jungil³,Heo Jeong³,Kim Yong‑Chul²,Han Sun‑Young¹

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Gyeongsangnam-do 52828, Republic of Korea

2. School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea

3. Gyeongnam Department of Environmental Toxicology and Chemistry, Korea Institute of Toxicology, Jinju, Gyeongsangnam-do 52834, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds;International Journal of Molecular Sciences;2023-11-28

2. Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship;European Journal of Medicinal Chemistry;2021-11

3. Development of UHPLC-MS/MS Method for Indirubin-3′-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in Rats;Molecules;2020-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP